The Weekly Summary
June 15th - June 21st
In the general news, Greece, once again, is poised to default on its debt. In the U.S., nine African-Americans were murdered while in church by a crazed white male gunman, once again. In the movies, Jurassic World broke all-time records earning $500 Million for the weekend.
In healthcare business news, Anthem (ANTM) made a $47 B bid for Cigna (CI), which was rejected. CVS (CVS) bought Target’s pharmacies and will rebrand them as CVS. Actavis (former ticker ACT) changed its name to Allergan and to ticker AGN, as the new company acquired Kythera (KYTH) for its double-chin-melting injection product Kybella.
On the data front, Biomarin’s (BMRN) drug to treat dwarfism, Vosoritide, succeeded sending shares higher. Also, Avalanche Biotech’s (AAVL) eye drug AVA-101 to treat AMD met endpoints.
From the FDA, Edwards’ (EW) Sapien 3 TAVR device was approved sooner than expected. Also Medtronic’s (MDT) Brio Neurostimulation System was approved.
In other regulatory news, the DOJ arrested hundreds of doctors and other medical professionals associated with an alleged $700 Million CMS billing fraud scheme.
The Weekly Summary, Uncategorized | apples49 | 
June 21, 2015 9:12 pm
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
